OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
4.580
+0.110 (2.46%)
Sep 21, 2026, 4:00 PM EDT - Market closed
OmniAb Market Cap
OmniAb has a market cap or net worth of $665.89 million as of September 21, 2026. Its market cap has increased by 187.31% in one year.
Market Cap
665.89M
Enterprise Value
632.81M
1-Year Change
187.31%
Ranking
Category
Stock Price
$4.58
ChartMarket Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $665.89M, a decrease of -32.94%. That is a compound annual growth rate of -9.71%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 665.89M | 150.04% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
| Oct 25, 2022 | 992.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MiMedx Group | 695.28M |
| Zevra Therapeutics | 689.45M |
| Sagimet Biosciences | 689.34M |
| Verastem | 673.79M |
| Aura Biosciences | 667.86M |
| Monopar Therapeutics | 647.52M |
| Neurogene | 642.17M |
| Altimmune | 632.18M |